David S. Block, M.D., has been appointed executive vice president of international operations at DuPont Pharmaceuticals. Previously, Block served as senior vice president of business development and strategic planning. In his new role, he will have
David S. Block, M.D., has been appointed executive vice president of international operations at DuPont Pharmaceuticals. Previously, Block served as senior vice president of business development and strategic planning. In his new role, he will have responsibility for profit and loss in all regions outside the U.S. and will be charged with growing these businesses. Block joined the company in 1990 as a product development manager for central nervous system products. He is also an assistant professor of medicine at Johns Hopkins Hospital in Baltimore and a member of the active attending staff in the Moore Clinic for HIV patients.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.